文献速递流行病学与生物统计基础与转化研究

维生素D与COVID-19易感性和严重性的孟德尔随机化研究

Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.
PubMed 文献 · PLoS Med · 2021-06-01

该研究采用两样本孟德尔随机化方法,利用443,734名欧洲血统参与者的25OHD水平GWAS遗传变异作为工具变量,评估循环25OHD水平对COVID-19易感性、住院和重症的因果效应。结果显示遗传预测的25OHD水平升高1个标准差与COVID-19易感性(OR=0.95)、住院(OR=1.09)和重症(OR=0.97)均无显著关联。结论不支持维生素D补充作为预防COVID-19恶化结局的手段。

要点

  • 遗传预测的25OHD水平与COVID-19易感性、住院和重症均无显著因果关联。
  • 维生素D补充作为预防COVID-19恶化结局的手段缺乏遗传证据支持。
  • 其他治疗或预防途径应优先纳入COVID-19随机对照试验。

核心结论

  • 本研究未观察到证据支持25OHD水平与COVID-19易感性、严重性或住院之间存在关联。
  • 遗传证据不支持维生素D补充作为预防COVID-19恶化结局的手段。

研究设计与样本

  • 两样本孟德尔随机化研究,使用443,734名欧洲血统参与者GWAS中与25OHD水平强关联的遗传变异作为工具变量。
  • 结局GWAS来自COVID-19 Host Genetics Initiative,包括多达14,134例COVID-19患者和1,284,876例无COVID-19者,来自多达11个国家。
  • SARS-CoV-2阳性通过实验室检测或病历审查确定,所有结局的对照组均包括无COVID-19的人群对照。
  • 分析尽可能限制在欧洲血统个体中。

主要发现

  • 遗传预测的25OHD水平每升高1个标准差(对数尺度)与COVID-19易感性无显著关联(OR=0.95;95%CI 0.84,1.08;p=0.44)。
  • 遗传预测的25OHD水平每升高1个标准差与COVID-19住院无显著关联(OR=1.09;95%CI 0.89,1.33;p=0.41)。
  • 遗传预测的25OHD水平每升高1个标准差与COVID-19重症无显著关联(OR=0.97;95%CI 0.77,1.22;p=0.77)。
  • 使用另外6种荟萃分析方法以及去除水平多效性风险变异后的敏感性分析获得相似结果。

临床怎么用

  • 不应基于维生素D补充可预防COVID-19恶化结局的假设开展相关临床试验。
  • COVID-19随机对照试验应优先考虑其他治疗或预防途径。

局限性

  • 部分分析可能受弱工具变量偏倚限制。
  • 结果不适用于维生素D缺乏个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increased vitamin D levels, as reflected by 25-hydroxy vitamin D (25OHD) measurements, have been proposed to protect against COVID-19 based on in vitro, observational, and ecological studies. However, vitamin D levels are associated with many confounding variables, and thus associations described to date may not be causal. Vitamin D Mendelian randomization (MR) studies have provided results that are concordant with large-scale vitamin D randomized trials. Here, we used 2-sample MR to assess evidence supporting a causal effect of circulating 25OHD levels on COVID-19 susceptibility and severity. METHODS AND FINDINGS: Genetic variants strongly associated with 25OHD levels in a genome-wide association study (GWAS) of 443,734 participants of European ancestry (including 401,460 from the UK Biobank) were used as instrumental variables. GWASs of COVID-19 susceptibility, hospitalization, and severe disease from the COVID-19 Host Genetics Initiative were used as outcome GWASs. These included up to 14,134 individuals with COVID-19, and up to 1,284,876 without COVID-19, from up to 11 countries. SARS-CoV-2 positivity was determined by laboratory testing or medical chart review. Population controls without COVID-19 were also included in the control groups for all outcomes, including hospitalization and severe disease. Analyses were restricted to individuals of European descent when possible. Using inverse-weighted MR, genetically increased 25OHD levels by 1 standard deviation on the logarithmic scale had no significant association with COVID-19 susceptibility (odds ratio [OR] = 0.95; 95% CI 0.84, 1.08; p = 0.44), hospitalization (OR = 1.09; 95% CI: 0.89, 1.33; p = 0.41), and severe disease (OR = 0.97; 95% CI: 0.77, 1.22; p = 0.77). We used an additional 6 meta-analytic methods, as well as conducting sensitivity analyses after removal of variants at risk of horizontal pleiotropy, and obtained similar results. These results may be limited by weak instrument bias in some analyses. Further, our results do not apply to individuals with vitamin D deficiency. CONCLUSIONS: In this 2-sample MR study, we did not observe evidence to support an association between 25OHD levels and COVID-19 susceptibility, severity, or hospitalization. Hence, vitamin D supplementation as a means of protecting against worsened COVID-19 outcomes is not supported by genetic evidence. Other therapeutic or preventative avenues should be given higher priority for COVID-19 randomized controlled trials.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Butler-Laporte G, Nakanishi T, Mooser V, et al. Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study. PLoS Med. 2021. PMID: 34061844. doi:10.1371/journal.pmed.1003605

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。